Strategic Experts

EDIS is a team of leaders comprising individuals with diverse, specialized and multi-disciplinary experience.

Mr. Lim Neo Chian
Senior Advisor

Mr. Lim is currently Chairman and Director of Ascendas Hospitality Trust Management Pte Ltd, Deputy Chairman of Gardens by the Bay, and Director of Singapore Cruise Centre Pte Ltd.

Mr. Lim was previously Chairman Jurong Town Corporation, CEO Jurong Town Corporation, CEO of China-Singapore Suzhou Industrial Park Development Co Ltd, Chairman of Bangalore IT Park Board’s EXCO, Deputy Chairman Singapore Economic Development Board, Deputy Chairman and Chief Executive of Singapore Tourism Board, Deputy Chairman and CEO of ST Engineering, Chairman of SCP Consultants and Chief of Army, Singapore Armed Forces.

During his stint in Jurong Town Corporation, Mr. Lim was involved in the planning and development of the Jurong Island Petrochemical Hub and the one-North project for the knowledge-driven industries.

For 10 years, Mr. Lim served as a Council Member of the Singapore Red Cross Society, stepping down as its Vice Chairman in 2011.

Mr. Lim graduated with a Bachelor of Engineering from Sheffield University, UK in 1975. Mr. Lim attended the Harvard Business School’s Program for Management Development in 1988, and Advanced Management Program in 2002.

Mr. Lim was conferred the Public Administration Medal (Gold)(Military) in 1993, Honorary Doctorate in Engineering by Sheffield University, UK, in 1996, and the Public Administration Medal (Gold) in 2003 for the handling of the tourism sector during the SARS period.


Mr. Shosaku Yasui
Senior Advisor

Mr. Shosaku Yasui is currently the Honorary Advisor of Teijin Limited, a leading Japanese chemicals and pharmaceutical company. Since joining Teijin in April 1957 upon graduating from the Faculty of Economics at Kyoto University, Mr. Yasui has risen through the ranks to become President and CEO of P.T. Teijin Indonesia in October 1988, Director of the Board of Teijin in June 1992, Managing Director of the Board of Teijin in June 1993, Senior Managing Director of the Board of Teijin in June 1994 and subsequently President of Teijin in June 1997. Mr. Yasui was subsequently appointed Chairman of Teijin Limited in November 2001.

In October 2008, Mr. Yasui was appointed Governor and Chief Executive Officer of Japan Finance Corporation, a policy-based financial institution that aims to complement financial activities carried out by private financial institutions which contributes to the improvement of the living standards of Japanese people. In October 2013, Mr. Yasui was appointed the Honorary Advisor of Teijin.

In recognition of his work in Teijin contributing to a close relationship with the Netherlands, Mr. Yasui was awarded the Officership of the Order of Orange Nassau by the government of the Netherlands in April 2002. In a similar was in relation to that for Luxembourg, Mr. Yasui was awarded the honorary title of the Commander of the Order of Merit of the Grand Duchy of Luxembourg by the government of Luxembourg in July 2005.


Sir David Lane
Scientific Advisor

Professor Sir David Lane is one of the scientists credited with the landmark discovery of cancer gene p53 in 1979. p53, called the “Guardian of the genome” is considered the most significant of all the genes altered in cancer cells because mutations of the gene are known to cause almost 50% of all human cancers.

Professor Lane is currently the Chief Scientist of the Singapore Agency for Science, Technology and Research (A*STAR), where his main role is to advise and engage in scientific development across the Biomedical Research Council (BMRC) and the Scientific Engineering Research Council (SERC) at the strategic level. He is the Director of the p53 Laboratory, which primarily focuses on research on p53 using both mammalian and zebrafish systems.

He was previously the Chairman of A*STAR’s Institute of Molecular and Cell Biology (IMCB) scientific advisory board from 2002-2003 and Executive Director, IMCB from 2004-2007, where he added on a translational focus to IMCB’s core strengths in basic R&D recruited many outstanding scientists and personally led efforts to foster greater collaboration, both within and outside of IMCB. He was also the founding CEO of A*STAR’s Experimental Therapeutics Centre, setup in 2006. Professor Lane put in place a robust team of more than 60 scientists and built up top-of-the-line technological platforms essential for the drug discovery business.

Professor Lane was the Chairman of BMRC from 2007-2009. During that time, he had been involved in charting out the strategic directions for all fourteen BMRC research institutes, consortia and centre in preparation for the next phase of Singapore’s Biomedical Initiative. Professor Lane was also involved in the establishment of A*STAR’s cross-disciplinary R&D initiatives, working closely with the Scientific Engineering Research Council (SERC) and the Cross Council Office (CCO) to further strengthen collaborations and explore new areas of multidisciplinary research. Professor Lane also helped foster collaborations with Scotland, culminating with a Memorandum of Understanding signed in 2006 between A*STAR and the University of Dundee to offer joint PhD training in biomedical sciences and explore opportunities for joint research collaborations.

Professor Lane completed his undergraduate and postgraduate degrees at University College London where he studied auto-immunity. He did his postdoctoral training at the Imperial Cancer Research Fund in London and then at the Cold Spring Harbor Labs in New York. On his return to UK, he established his independent research lab at Imperial College London before moving to the University of Dundee. He is also the founder of Cyclacel Pharmaceuticals Inc., a biotechnology company developing novel drugs for the treatment of cancer, with three oncology drug candidates in clinical trials.

He was previously the Director of the Cancer Research UK Cell Transformation Research Group and Professor of Oncology at the University of Dundee in Scotland. He currently holds a concurrent appointment as the Chief Scientist with Cancer Research UK.

For his efforts in cancer research, Professor Lane was knighted in 2000 and has won many awards such as the Paul Ehrlich Prize in 1998, the Buchanan Medal in 2004, and the Medal of Honor from the International Agency for Research on Cancer in 2005 and recently in 2008, the Royal Medal from the Royal Society of Edinburgh. He is a member of the European Molecular Biology Organisation (EMBO) and a Fellow of UK’s premier scientific academy, the Royal Society, the Royal Society of Edinburgh and a founder member of the Academy of Medical Science.

Professor Lane has been awarded Honorary Degrees from the University of Abertay, University of Stirling, University of Aberdeen, University of Birmingham, University of Nottingham and the University Paul Sabatier, Toulouse.

Professor Lane has published more than 300 research articles in international peer reviewed journals many of which have been very highly citied and has co-authored a successful practical guide to the use of immunochemical methods called “Antibodies” with Ed Harlow, selling more than 40,000 copies.


Dr. Goh Song How
Development Advisor

Dr. Tony Goh was born in Singapore in 1951. Having graduated from the National Junior College in 1970, Dr. Goh received a Colombo Plan Scholarship to study engineering and economics in the Newcastle University of Australia. He graduated with a first class honour degree in Civil Engineering and a bachelor degree in Economics.

Starting his career in 1976 as a civil engineer with the Ministry of Defence, Dr. Goh became the Director, Lands & Estates Organisation in the same Ministry in 1983. During this tenure, he attained his professional engineer status in Singapore and Australia respectively and also received a Master Degree in Construction Engineering from the National University of Singapore.

Dr. Goh left the Ministry in 1991 to join the then Singapore Technology Industrial Corporation (now Sembcorp Industries), holding various senior executive appointments such as Director for Riau Project Division; Managing Director for Overseas Infrastructure Group and President of SembPark Group. During the 10 year period in these positions, Dr. Goh spear-headed the development and operations of several industrial parks, hotels and golf resorts in Indonesia, China and Vietnam. He also held more than 80 directorships, both local and overseas during his career.

In 2001, Dr. Goh joined the Jurong Town Corporation (JTC) and helped to corporatise its Technical Service Group into a Government owned private limited company. Serving as its first President and Group CEO of JURONG International Holdings (JIH) Pte Ltd, Dr. Goh had developed JIH into Singapore’s leading international consultancy service provider with twenty-two global subsidiaries, offering master planning and engineering expertise to global customers.

Dr. Goh left the Group at the end of his contract service in 2006 to complete a full-time doctorate degree in business administration with the University of South Australia. He also founded his own business advisory company, LEOSEN International which offers development consultancy and business advisory services. Dr. Goh’s expertise centres on large scale development planning and company’s operations.


Mr. Stephen Yeo
ICT Advisor

Mr. Stephen Yeo is the founder/director of S2S Consulting. He is also currently director of NTUCLink Pte Ltd and on the board of advisors NTU Graduate Business School.

He began his career in Singapore Ministry of Defence where as director of Systems and Computers he spearheaded the introduction of ICT in command and control systems. He was CEO National Computer Board, Singapore from 1995 to 1999, where he promoted the development of e-Government and ICT in healthcare, education, trade and economic development. He then moved to the commercial sector for the next 14 years where he served as CEO SCS Ltd, President of EDS International (SE Asia) and CEO British Telecom SE Asia.

Mr. Yeo consults with companies in the area of leveraging ICT for strategic advantage. He also helps nurture emerging ICT companies.

In the past 20 years he has served on the boards of companies, statutory boards and educational institutions.

Mr. Yeo graduated from Oxford University, UK in Engineering Science, obtained an MSc in Singapore NUS and an MBA from USC, California.


Mr. Wong Kai Yeng
Urban Planning Advisor

Mr. Wong Kai Yeng is a Consultant for Economic Development Innovations Singapore Pte Ltd, specialising in master planning. He has experience in land use planning, infrastructure planning and design, as well as port operations.

After graduating with an engineering degree from the University of Cambridge, he started as an engineer in the then Ministry of the Environment, designing drainage systems, and designing, constructing and operating wastewater treatment plants. In the 1990s, as Director of the Physical Planning Division in the Urban Redevelopment Authority (URA), he led the planning team in developing the long term land use Concept Plan, the Master Plan and the Development Guide Plans for Singapore.

Mr. Wong subsequently joined PSA Corporation, heading the Engineering Division. He was responsible for the operational readiness of port equipment as well as the physical expansion of PSA ports in Singapore, China, Yemen, South Korea, India and Portugal. In the mid-2000s, he spent a few years in PUB as Director of Planning & Policy, focussing on water resource management including the development of NEWater.

In 2006, Mr. Wong was appointed Group Director in the URA, setting up the URA International unit to share URA’s planning expertise in the international arena. He was extensively involved in the master planning of Tianjin Eco City and also participated in planning consultancy projects in Guangzhou, Nantong, Nanjing, Qatar and Mumbai.

Mr. Wong subsequently joined Singbridge International and was involved in projects in Myanmar and Malaysia. He is currently on the Centre For Liveable Cities (CLC) Expert Panel.


Mr. Thomas Chhoa
Senior Advisor

Thomas joined Shell in the Netherlands back in early ‘80s after graduating as an engineer in the UK. Since then, he had a number of international assignments across the world. In the Netherlands, Thomas was involved in technical project development and process design work for projects in various countries. He was then assigned to Al-Jubail in Saudi Arabia where he worked for the Petromin-Shell Refinery Company during the construction, start-up and early operation period of the multi-billion green field Refinery complex. Thomas moved to Hong Kong and then China in 1992 where he was based in Beijing for 4 years to develop a world scale Joint Venture Petrochemicals project in Daya Bay, now successfully operating as CNOOC Shell Petrochemicals Company Ltd. His further stint with manufacturing and production, change and commercial management was at Clyde Refinery in Sydney Australia between 1996 and 1999.

In Shell’s Gas & Power division, he led the Coal Gasification/Clean Coal strategy and business development between 2003 and 2007, resulting in a successful JV with Sinopec and numerous Shell technology transfer agreements. As the General Manager for Shell’s Downstream Chemicals Ethylene Oxide and Glycols based in Singapore between 2007 and 2010, Thomas was responsible for the global business performance of a core product line. He oversaw the successful placement of Mono-ethylene Glycols from Shell’s new world scale proprietary OMEGA facilities in Jurong island as well as the re-marketing of Canada’s Scotford production back into the Americas. From 2010 till 2013, he was the lead Business Opportunity Manager/Venture Director for the development of a JV Petrochemicals project with Qatar Petroleum in Qatar. Back in Singapore at the head office of Shell Integrated Gas, he was the Global General Manager for Shell’s development of LNG as a transport fuel until his recent retirement in June 2016.

Thomas was vice Chairman of the board for Yueyang Sinopec Shell Coal Gasification Company Ltd., and he has been a board member of Shell Eastern Trading (Pte.) Ltd.